Yves Joseph Ribeill
Chief Executive Officer at Ribogenics, Inc.
Net worth: 44 583 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Angulo Gonzalez | M | 59 | 9 years | |
| Guy MacDonald | M | 65 | 10 years | |
| Laurent Arthaud | M | 61 |
Ribogenics, Inc.
 Ribogenics, Inc. BiotechnologyHealth Technology Ribogenics, Inc. is a biotechnology company. The private company is based in Philadelphia, PA. The CEO of the company is Yves Joseph Ribeill. | 15 years |
| David Hastings | M | 62 | 9 years | |
| Ann Hanham | M | 71 | 16 years | |
| Graeme Fraser | M | - |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | - |
| Steven Gilman | M | 71 | 9 years | |
| Jean Combalbert | M | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | - |
| Raf Moons | M | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | - |
| Alain Parthoens | M | 64 |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | - |
| Al Gray | M | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | 25 years |
| Michel Allé | M | 74 |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | - |
| Philippe Degive | M | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | - |
| Vincent Lannoy | M | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | 24 years |
| Philippe Monteyne | M | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | - |
| Jean-Paul Prieels | M | 78 |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | - |
| Hamid Hoveyda | M | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | 17 years |
| Steven Ramael | M | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | - |
| Wei Zhang | M | - |
Ribogenics, Inc.
Ribogenics, Inc. BiotechnologyHealth Technology Ribogenics, Inc. is a biotechnology company. The private company is based in Philadelphia, PA. The CEO of the company is Yves Joseph Ribeill. | - |
| Serge Braun | M | - |
Ribogenics, Inc.
Ribogenics, Inc. BiotechnologyHealth Technology Ribogenics, Inc. is a biotechnology company. The private company is based in Philadelphia, PA. The CEO of the company is Yves Joseph Ribeill. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marco Taglietti | M | 64 | 8 years | |
| Jean-Yves Nothias | M | 62 | 15 years | |
| Jean-Jacques Bertrand | M | 84 |
Aventis Pharma SARL
 Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the private company is based in Antony, France. | - |
| Clarence Machado | M | 60 | 4 years | |
| Edward Penhoet | M | 83 | 13 years | |
| Patrick J. Langlois | M | 78 | - | |
| Pamela Kirby | M | 70 | 11 years | |
| Jean-Pierre Labroue | M | 60 |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the private company is based in Antony, France. | 5 years |
| Mounia Chaoui-Roulleau | M | 52 | 2 years | |
| Philippe Chauveau | M | 88 | 7 years | |
| Terry Eugene Marquardt | F | - | - | |
| Michael C. Garrett | M | 59 | - | |
| Scot Kevin Huber | M | - | - | |
| David Chaplin | M | 68 |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the private company is based in Antony, France. | 1 years |
| Pierre Bernard Jacques Monnet | M | - | - | |
| Russell J. Outcalt | M | - | - | |
| David R. Houck | M | - | 3 years | |
| Rajeshwar Motheram | M | - | - | |
| Eric Francois | M | 49 | 6 years | |
| Amanda S. Mancuso | F | 51 | - | |
| Carole A. Sable | M | 62 | 1 years | |
| Marie-Christine Bissery | M | - |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the private company is based in Antony, France. | 4 years |
| Marie Paule Richard | M | 72 |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the private company is based in Antony, France. | 7 years |
| Samuel Hopkins | M | - | - | |
| Eileen C. Pruette | F | 65 | 2 years | |
| Matthias Zachert | M | 56 |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the private company is based in Antony, France. | - |
| Jonathan Sears Woodall | M | 64 | - | |
| Gilles Brisson | M | 72 |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the private company is based in Antony, France. | - |
| Charles Osborne | M | 58 | 12 years | |
| Brian Schwab | M | 59 | 9 years | |
| Andrew Novak | M | 42 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 32 | 62.75% |
| Belgium | 12 | 23.53% |
| France | 7 | 13.73% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yves Joseph Ribeill
- Personal Network
